News & Insights

Claret Capital Fallback Featured Placeholder image

Claret Insight 12 May 2026

Venture debt as an option for start-up companies

View Venture debt as an option for start-up companies

Claret Insight 5 May 2026

Europe’s Space Economy Needs a Broader Capital Stack

View Europe’s Space Economy Needs a Broader Capital Stack

Investment Announcement 31 Mar 2026

Claret Capital Partners Strengthens Partnership with Paysend Through US$25M Follow-On Investment

View Claret Capital Partners Strengthens Partnership with Paysend Through US$25M Follow-On Investment

Investment Announcement 23 Mar 2026

Claret Capital Partners Extends €10M in Financing to Wellster Healthtech to Support European Expansion

View Claret Capital Partners Extends €10M in Financing to Wellster Healthtech to Support European Expansion

Portfolio News 17 Mar 2026

Samsung Ventures joins GridBeyond’s shareholder base as part of a €12M equity investment

View Samsung Ventures joins GridBeyond’s shareholder base as part of a €12M equity investment

Investment Announcement 13 Mar 2026

Claret Capital Partners Invests €28M in Cinclus Pharma

View Claret Capital Partners Invests €28M in Cinclus Pharma

Investment Announcement 10 Mar 2026

Claret Capital Partners Announces Investment in U.S.-based ACT LAB

View Claret Capital Partners Announces Investment in U.S.-based ACT LAB

Portfolio News 11 Feb 2026

Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis

View Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis